Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients

被引:0
|
作者
Pinelli, Valentina
Fini, Donatella
Battolla, Enrico
Ferro, Paola
Franceschini, Maria Cristiana
Fontana, Vincenzo
Pistillo, Maria Pia
Roncella, Silvio
Canessa, Pier Aldo
机构
关键词
Mesothelioma; Pleura; Biomarkers;
D O I
10.1183/13993003.congress-2016.PA5075
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA5075
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Serum Fibulin-3 Levels In Patients With Mesothelioma And Pleural Plaques And Healthy Subjects Exposed To Naturally Occurring Asbestos
    Bayram, M.
    Akkoyunlu, M.
    Dongel, I.
    Akbas, A.
    Benli, I.
    Kart, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [42] Fibulin-3 immunoexpression in malignant mesothelioma due to fluoro-edenite: a preliminary report
    Caltabiano, Rosario
    Loreto, Carla
    Vitale, Ermanno
    Matera, Serena
    Miozzi, Edoardo
    Migliore, Marcello
    Angelico, Giuseppe
    Tumino, Rosario
    Ledda, Caterina
    Rapisarda, Venerando
    FUTURE ONCOLOGY, 2018, 14 (06) : 53 - 57
  • [43] Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma (vol 367, pg 1417, 2012)
    Pass, Harvey, I
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1768 - 1768
  • [44] Kinetics of Soluble Mesothelin in Patients with Malignant Pleural Mesothelioma during Treatment
    Grigoriu, Bogdan D.
    Chahine, Bachar
    Vachani, Anil
    Gey, Thomas
    Conti, Massimo
    Sterman, Daniel H.
    Marchandise, Genevieve
    Porte, Henri
    Albelda, Steven M.
    Scherpereel, Arnaud
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (10) : 950 - 954
  • [45] A Retrospective Evaluation of 64 Hospitalised Malignant Pleural Mesothelioma (MPM) Patients
    Ustamujic, Aida
    Cukic, Vesna
    Catovic-Pecanac, Elmedina
    Dizdarevic-Spago, Dina
    Sladic, Irma
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1381 - S1381
  • [46] Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Santoro, A.
    Ceresoli, G. L.
    Marangolo, M.
    Mencoboni, M.
    Zucali, P.
    Favaretto, A.
    Grossi, F.
    Bearz, A.
    Botta, M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S18 - S18
  • [47] A phase II trial of gefitinib in patients with malignant pleural mesothelioma (MPM)
    Lee, C. W.
    Anderson, H.
    Martins, H.
    Rao, S. C.
    Sauciuc, D.
    Laurie, S. A.
    Morzycki, W.
    MacNeil, M. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] Malignant pleural mesothelioma (MPM): Analysis of 78 consecutive patients (pts)
    Giovannini, Monica
    Terzi, Alberto
    Genestreti, Giovenzio
    Fiorio, Elena
    Lonardoni, Alessandro
    Falezza, Giovanni
    Magnanelli, Giovanni
    Maluta, Sergio
    Calabro, Francesco
    Cetto, Gian Luigi
    Santo, Antonio
    ANNALS OF ONCOLOGY, 2005, 16 : 25 - 26
  • [49] PET/CT in the preoperative evaluation of patients with malignant pleural mesothelioma (MPM)
    Gregianin, M.
    Rossi, F. Dei
    Cracco, E.
    Zaccaria, A.
    Canton, A.
    Pagan, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S142 - S142
  • [50] Malignant pleural mesothelioma (MPM): analysis of consecutive 100 patients (pts)
    Abou-Elkasem, F
    Gaafar, R
    Abdelrahman, A
    Abdelbaki, H
    Hassan, N
    PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 107 - 112